1. Home
  2. NEO vs TY Comparison

NEO vs TY Comparison

Compare NEO & TY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$15.90

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Tri Continental Corporation

TY

Tri Continental Corporation

HOLD

Current Price

$36.02

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
TY
Founded
2001
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
NEO
TY
Price
$15.90
$36.02
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$13.38
N/A
AVG Volume (30 Days)
3.0M
26.6K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
3.36%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.63
N/A
Revenue Next Year
$9.73
N/A
P/E Ratio
N/A
$7.50
Revenue Growth
N/A
N/A
52 Week Low
$5.94
$30.53
52 Week High
$16.92
$36.55

Technical Indicators

Market Signals
Indicator
NEO
TY
Relative Strength Index (RSI) 57.99 65.74
Support Level $13.43 $34.19
Resistance Level N/A N/A
Average True Range (ATR) 0.69 0.52
MACD -0.01 0.09
Stochastic Oscillator 74.42 73.94

Price Performance

Historical Comparison
NEO
TY

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About TY Tri Continental Corporation

Tri-Continental Corp is a closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.

Share on Social Networks: